IRCT201202198983N1已完成未知
Evaluation of Intravitreal injection of Bevacizumab for treatment of Chronic Central Serous Chorioretinopathy
Guilan Universoty of Medical Sciences, Pro-vice-chancellor for resea0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 50 years（—）
- 性别
- All
入选标准
- •Inclusion criteria :
- •1- patient by Acute Central Serous Chorioretinopathy for more than 4-months.
- •2- Comformation of The Chronic Central Serous Chorioretinopathy byOcular Coherent Tomography(OCT) and Fluorescien Angiography (FFA) .
- •3- comfirmation of the Diseasis by Supervisor of Study.
- •Exclusion criteria:
- •1- Chronic Central Serous Chorioretinopathy more than 2 years.
- •2- History of Treatment by any type of Laser.
- •3-History of Thromboambolic Diseasis Like Myocardial Infarction and Cerebro Vascular accident.
- •4- History of Treatment by Intravitreal Avastin during 2 months ago.
- •5- any sistemic Diseasis that need Oral Corticosteroid Thrapy.
- •6- un - Controled Glaucoma
- •7- Pregnancy
- •8- Lack of agreement by Patient for periodic Follow up during study.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
The effect of intravitreal injection of bevacizumab after vitrectomy for proliferative diabetic retinopathyproliferative diabetic retinopathyJPRN-UMIN000009801Tokyo medical university20
招募中
2 期
Comparison of intravitreal anti-VEGF drug and steroid in the treatment of uveitic macular edemaMacular edema in uveitic eyes.Chorioretinal inflammation, unspecifiedIRCT2016100930224N1Vice chancellor for research, Shiraz University of Medical Sciences60
已完成
不适用
The effect of intra-vitreal injection of bevacizumab for vascular endothelial factor-related intraocular diseases.choroidal neovascularization, retinal vein occlusion, diabetic retinopathy, diabetic maculopathy, neovascular glaucomaJPRN-UMIN000013974Department of Ophthalmology, Matsumoto Dental University3
已完成
不适用
Safety and effectiveness of intravitreal bevacizumab and ranibizumab injections for treatment of retinal disease patients: an observational studyretinal diseases or conditions that can be treated with bevacizumab or ranibizumab such as neovascular age-related macular degeneration (neovascular AMD),diabetic macular edema (DME),and macular edeneovascular age-related macular degeneration (neovascular AMD)diabetic macular edema (DME)retinal vein occlusion(RVO)TCTR20141002001Health Intervention and Technology Assessment Program (HITAP)6,399
已完成
2 期
Safety and efficacy of intra-vitreal bevacizumab combined with supra-choroidal triamcinolone in the treatment of central retinal vein occlusion.Macular edemaEye - Diseases / disorders of the eyeCentral retinal vein occlusionACTRN12622000267752Salahuddin34